Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial

scientific article published on 23 December 2015

Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/14767058.2015.1121478
P698PubMed publication ID26698911

P50authorElisabetta PetrellaQ43571851
Isabella NeriQ59158587
P2093author name stringFabio Facchinetti
Antonino Di Benedetto
Basilio Pintaudi
Francesco Corrado
Rosario D'Anna
Angelo Santamaria
P2860cites workPotential role and therapeutic interests of myo-inositol in metabolic diseasesQ28292692
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetesQ34026140
myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled studyQ34035221
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndromeQ34116177
Diagnosis and classification of diabetes mellitusQ34425060
Hyperglycemia and adverse pregnancy outcomesQ34777029
Increased risk of cardiovascular disease in young women following gestational diabetes mellitusQ36807480
Gestational diabetes mellitus: a review from 2004.Q37065544
Dietary interventions, lifestyle changes, and dietary supplements in preventing gestational diabetes mellitus: a literature reviewQ38269526
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled TrialQ41515750
Normal and abnormal maternal metabolism during pregnancyQ46262499
Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndromeQ46706686
Italian risk factor-based screening for gestational diabetes.Q50758847
Improvement of selective screening strategy for gestational diabetes through a more accurate definition of high-risk groups.Q50799668
Longitudinal changes in insulin release and insulin resistance in nonobese pregnant womenQ54284181
P433issue19
P921main subjectobesityQ12174
gestational diabetesQ126691
P304page(s)3234-3237
P577publication date2015-12-23
P1433published inJournal of Maternal-Fetal and Neonatal MedicineQ6295498
P1476titleMyo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial
P478volume29

Reverse relations

cites work (P2860)
Q90420566Attenuating Pregnancy Weight Gain-What Works and Why: A Systematic Review and Meta-Analysis
Q90210722Drugs to Control Diabetes During Pregnancy
Q92536418Expression of myo-inositol cotransporters in the sciatic nerve and dorsal root ganglia in experimental diabetes
Q91809506Gestational diabetes mellitus
Q38875540Gestational diabetes mellitus: does an effective prevention strategy exist?
Q95320543High placental inositol content associated with suppressed pro-adipogenic effects of maternal glycaemia in offspring: the GUSTO cohort
Q92481688Inositol and antioxidant supplementation: Safety and efficacy in pregnancy
Q33707644Maternal nutrition: opportunities in the prevention of gestational diabetes
Q42635246Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials
Q92313815Myoinositol in the Prevention of Gestational Diabetes Mellitus: Is It Sensible?
Q61817700Nutraceuticals Inspiring the Current Therapy for Lifestyle Diseases
Q37363630The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes.
Q92997243The effect of exercise on the prevention of gestational diabetes in obese and overweight pregnant women: a systematic review and meta-analysis
Q38809632Windows of Opportunity for Lifestyle Interventions to Prevent Gestational Diabetes Mellitus

Search more.